This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Academia Sinica, Taipei Medical University. Active years: 2016.
Company Filing History:
1 out of 726 
1 out of 146 
Years Active: 2016
Title: The Innovations of Ming-Chi Peng
Introduction
Ming-Chi Peng is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of endometriosis. His work has implications for improving the accuracy of diagnoses and enhancing patient care.
Latest Patents
Ming-Chi Peng holds a patent for "Specific A1AT monoclonal antibodies for detection of endometriosis." This patent describes monoclonal antibodies with a high binding affinity to isoforms of alpha 1-antitrypsin (A1AT). The invention includes hybridoma cells that produce these antibodies and outlines their uses in diagnosing and detecting endometriosis from serum samples of subjects suspected of having the condition or undergoing health examinations. He has 1 patent to his name.
Career Highlights
Throughout his career, Ming-Chi Peng has worked with prestigious institutions such as Academia Sinica and Taipei Medical University. His research has focused on developing innovative solutions for medical challenges, particularly in the realm of women's health.
Collaborations
Ming-Chi Peng has collaborated with esteemed colleagues, including Wei-Chung Yang and Shui-Tsung Chen. Their joint efforts have contributed to advancements in medical research and diagnostics.
Conclusion
Ming-Chi Peng's work exemplifies the impact of innovation in medical diagnostics. His contributions, particularly in the detection of endometriosis, highlight the importance of research in improving healthcare outcomes.